High Prevalence of Pulmonary Arterial Hypertension and Emergence of Covid-19 to Augment Growth of Iloprost Drugs Market

Iloprost Drugs Market


Iloprost is used for the treatment of certain kinds of pulmonary arterial hypertension. It is antithrombotic, anti-inflammatory, and antifibrotic. An inhaled formulation of iloprost, sold as Ventavis, is approved by the FDA for the treatment of pulmonary arterial hypertension.

Market Dynamics 

High prevalence of pulmonary arterial hypertension is expected to propel growth of the iloprost drugs market. For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million.

Moreover, R&D in iloprost is also expected to aid in the growth of the market. For instance, in October 2020, CiVi Biopharma resumed patient enrollment for a Phase 3 trial testing iloprost, known as CIVI030, for the treatment of Raynaud’s phenomenon due to scleroderma. The study was previously forced to a temporary halt in March 2020, due to the COVID-19 pandemic.

The emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the iloprost drugs market. For instance, globally, as of 6:51pm CET, 13 January 2021, there have been 90,335,008 confirmed cases of COVID-19, including 1,954,336 deaths, as reported to the World Health Organization. Iloprost has potential in the treatment of COVID-19-related vasculopathy. 

Iloprost can aid in minimizing the lung damage and thrombotic complications seen in COVID-19 as it can restore healthy endothelial function. Thus, increasing funding for R&D in iloprost is also expected to aid in growth of the market. For instance, in May 2020, BioPorto A/S, a Denmark-based in-vitro diagnostic company, noted that Innovation Fund Denmark has awarded US$ 402,179 to test if the drug Iloprost can improve survival rates in SARS-Co-V2 infected patients in need of respiratory treatment.

Competitive Analysis 

Major operating in the iloprost drugs market include, Actelion Pharmaceuticals, Bayer AG, Vectura Group Plc., CiVi Biopharma, and VisionGate. 

Major operating in the iloprost drugs market are focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in August 2019, VisionGate, Inc., a clinical stage oncology pharmaceutical and diagnostics company, signed an exclusive worldwide license agreement with Bayer AG regarding iloprost betadex clathrate and a manufacturing and supply agreement for the substance iloprost.

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more